drugset / Trial / NCT00923533
A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers
Non-randomizedCrossoverOpen-label
Summary
To evaluate drug-drug interaction between fimasartan and hydrochlorothiazide.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-05
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fimasartan | Small molecule | 240 mg | Oral |
| Comparator | Hydrochlorothiazide | Unknown | 25 mg | Oral |